EP2046295A1 - Herstellung von pharmazeutischen zusammensetzungen - Google Patents

Herstellung von pharmazeutischen zusammensetzungen

Info

Publication number
EP2046295A1
EP2046295A1 EP07766448A EP07766448A EP2046295A1 EP 2046295 A1 EP2046295 A1 EP 2046295A1 EP 07766448 A EP07766448 A EP 07766448A EP 07766448 A EP07766448 A EP 07766448A EP 2046295 A1 EP2046295 A1 EP 2046295A1
Authority
EP
European Patent Office
Prior art keywords
paracetamol
water
nsaid
carrier
solvent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
EP07766448A
Other languages
English (en)
French (fr)
Inventor
Andrew James Elphick
John Staniforth
Dong Wang
David John Duncalf
Steven Paul Rannard
James Long
Alison Jayne Foster
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Iota Nanosolutions Ltd
Original Assignee
Unilever PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB0613925.7A external-priority patent/GB0613925D0/en
Application filed by Unilever PLC filed Critical Unilever PLC
Priority to EP07766448A priority Critical patent/EP2046295A1/de
Publication of EP2046295A1 publication Critical patent/EP2046295A1/de
Ceased legal-status Critical Current

Links

Definitions

  • 2- Arylpropionic acids include: Ibuprofen, Carprofen, Fenbufen, Fenoprofen, Flurbiprofen, Ketoprofen, Ketorolac, Loxoprofen, Naproxen, Tiaprofenic acid and Suprofen.
  • N-Arylanthranilic acids include: Mefenamic acid and Meclofenamic acid.
  • Pyrazolidine derivatives include: Phenylbutazone, Azapropazone, Metamizole, Oxyphenbutazone and Sulfinprazone.
  • Oxicams include: Piroxicam, Lornoxicam, Meloxicam and Tenoxicam.
  • WO 2005/011636 discloses a non-emulsion based spray drying process for forming "solid amorphous dispersions" of drugs in polymers.
  • a polymer and a low-solubility drug are dissolved in a solvent and spray-dried to form dispersions in which the drug is mostly present in an amorphous form rather than in a crystalline form.
  • Unpublished co-pending applications (GB 0501835 of 28 January 2005 and GB 0613925 filed on 13 July 2006) describe how materials which will form a nano- dispersion in water can be prepared, preferably by a spray-drying process. In the first of these applications the water insoluble materials is dissolved in the solvent- phase of an emulsion.
  • the products obtainable by the process aspects of the present invention are suitable for use in the preparation of medicaments for treatment of pain.
  • Sonication is also a particularly preferred way of reducing the droplet size for emulsion systems.
  • a Hert Systems Sonicator XL operated at level 10 for two minutes is suitable.
  • the carrier material is water soluble, which includes the formation of structured aqueous phases as well as true ionic solution of molecularly mono-disperse species.
  • Alkoxylated nonionics especially the PEG/PPG PluronicTM materials
  • phenol- ethoxylates especially TRITONTM materials
  • alkyl sulphonates especially SDS
  • ester surfactants preferably sorbitan esters of the SpanTM and TweenTM types
  • cationics especially cetyltrimethylammonium bromide - CTAB
  • Particularly preferred solvents are alcohols, particularly ethanol and halogenated solvents, more preferably chlorine-containing solvents, most preferably solvents selected from (di- or trichloromethane).
  • 0.20 g Paracetamol, 0.40 g Klucel EF, 0.10 g Pluronic Fl 27, 0.10 g Tween 80, and 0.20 g Mannitol are all dispersed into 50 ml absolute ethanol.
  • the ethanol suspension is stirred intensively with a magnetic bar for about half hour before added 30 ml distilled water. A clear solution is obtained. ⁇

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
EP07766448A 2006-07-13 2007-07-13 Herstellung von pharmazeutischen zusammensetzungen Ceased EP2046295A1 (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP07766448A EP2046295A1 (de) 2006-07-13 2007-07-13 Herstellung von pharmazeutischen zusammensetzungen

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB0613925.7A GB0613925D0 (en) 2006-07-13 2006-07-13 Improvements relating to nanodispersions
PCT/EP2007/056560 WO2008006712A2 (en) 2006-07-13 2007-06-29 Preparation of nanodispersions
EP07766448A EP2046295A1 (de) 2006-07-13 2007-07-13 Herstellung von pharmazeutischen zusammensetzungen
PCT/GB2007/050407 WO2008007150A1 (en) 2006-07-13 2007-07-13 Preparation of pharmaceutical compositions

Publications (1)

Publication Number Publication Date
EP2046295A1 true EP2046295A1 (de) 2009-04-15

Family

ID=40429822

Family Applications (1)

Application Number Title Priority Date Filing Date
EP07766448A Ceased EP2046295A1 (de) 2006-07-13 2007-07-13 Herstellung von pharmazeutischen zusammensetzungen

Country Status (1)

Country Link
EP (1) EP2046295A1 (de)

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO2008007150A1 *

Similar Documents

Publication Publication Date Title
US8945626B2 (en) Preparation of pharmaceutical compositions
US20110217381A1 (en) Pharmaceutical compositions
EP2046295A1 (de) Herstellung von pharmazeutischen zusammensetzungen
EP2046296A2 (de) Verfahren zur herstellung von pharmazeutischen zusammensetzungen
EP2046297A2 (de) Herstellung von pharmazeutischen formulierungen

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20090126

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL BA HR MK RS

17Q First examination report despatched

Effective date: 20090422

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: UNILEVER N.V.

Owner name: UNILEVER PLC

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: IOTA NANOSOLUTIONS LIMITED

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: IOTA NANOSOLUTIONS LIMITED

DAX Request for extension of the european patent (deleted)
REG Reference to a national code

Ref country code: DE

Ref legal event code: R003

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN REFUSED

18R Application refused

Effective date: 20140207

19U Interruption of proceedings before grant

Effective date: 20130603

19W Proceedings resumed before grant after interruption of proceedings

Effective date: 20220401